Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER at ANNX; Chief Financial Officer at CHINOOK THERAPEUTICS, INC.; VP, Finance & PAO at DYNAVAX TECHNOLOGIES CORP
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 31
- Latest Mar 2, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- ANNXAnnexon, Inc.EVP & CHIEF FINANCIAL OFFICER
- CHINOOK THERAPEUTICS, INC.Chief Financial Officer
- DYNAVAX TECHNOLOGIES CORPVP, Finance & PAO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CHINOOK THERAPEUTICS, INC.138,884 shares
- ANNX43,702 shares
- DYNAVAX TECHNOLOGIES CORP18,750 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice ANNXNoticeFeb 13, 2025 2025
Filed to sell 1,786 shares ($5k)
Lew Jennifer, Officer
No 10b5-1 plan1x usual sizeFiling
- 2 Form 4 sale ANNXNo planFeb 13, 2025 same day
Sold 1,786 shares at $2.98 ($5k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 2.1% of holdings ($258k position)84,682 shares left1.2x usual sizeFollows a Form 144Filing
- 3 Form 144 notice ANNXNoticeFeb 18, 2025 +5 days
Filed to sell 8,338 shares ($24k)
Lew Jennifer, Officer
No 10b5-1 plan4.7x usual sizeFiling
- 4 Form 4 sale ANNXUnusualFeb 18, 2025 same day
Sold 6,912 shares at $2.92 ($20k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 8.2% of holdings ($247k position)77,770 shares left3.9x usual sizeFollows a Form 144Filing
- 5 Form 144 notice ANNXNoticeJul 14, 2025 +146 days
Filed to sell 1,117 shares ($3k)
Lew Jennifer, Officer
No 10b5-1 plan0.6x usual sizeFiling
- 6 Form 4 sale ANNXNo planJul 14, 2025 same day
Sold 1,117 shares at $2.58 ($3k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 0.9% of holdings ($317k position)121,616 shares left0.6x usual sizeFollows a Form 144Filing
- 7 Form 4 sale ANNXUnusualFeb 18, 2026 +219 days
Sold 7,851 shares at $5.11 ($40k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 6.5% of holdings ($621k position)113,765 shares left4.4x usual sizeFiling
- 8 Form 4 sale ANNXUnusualMar 2, 2026 +12 days
Sold 5,565 shares at $5.42 ($30k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 3.2% of holdings ($955k position)170,700 shares left3.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (38)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4, 2026 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 5,565 | $30k | 3.2% | Unusual | SEC |
| Feb 18, 2026 | Feb 20, 2026 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 7,851 | $40k | 6.5% | Unusual | SEC |
| Jul 14, 2025 | Jul 16, 2025 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,117 | $3k | 0.9% | No plan | SEC |
| Jul 14, 2025 | Jul 14, 2025 | ANNX | Officer | Form 144 notice | 1,117 | $3k | Notice | SEC | |
| Feb 18, 2025 | Feb 20, 2025 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 6,912 | $20k | 8.2% | Unusual | SEC |
| Feb 18, 2025 | Feb 18, 2025 | ANNX | Officer | Form 144 notice | 8,338 | $24k | Notice | SEC | |
| Feb 13, 2025 | Feb 18, 2025 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,786 | $5k | 2.1% | No plan | SEC |
| Feb 13, 2025 | Feb 13, 2025 | ANNX | Officer | Form 144 notice | 1,786 | $5k | Notice | SEC | |
| Jul 15, 2024 | Jul 17, 2024 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,104 | $7k | 1.3% | No plan | SEC |
| Jul 15, 2024 | Jul 15, 2024 | ANNX | Officer | Form 144 notice | 1,104 | $7k | Notice | SEC | |
| Feb 20, 2024 | Feb 21, 2024 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 2,593 | $14k | 3.1% | No plan | SEC |
| Feb 20, 2024 | Feb 20, 2024 | ANNX | Officer | Form 144 notice | 2,593 | $14k | Notice | SEC | |
| Feb 12, 2024 | Feb 14, 2024 | ANNX | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,809 | $10k | 3.8% | No plan | SEC |
| Feb 12, 2024 | Feb 12, 2024 | ANNX | Officer | Form 144 notice | 1,809 | $10k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | ANNX | Officer | Form 144 notice | 1,057 | $4k | Notice | SEC | |
| Jul 11, 2023 | Jan 23, 2024 | ANNX | EVP & Chief Financial Officer | Form 4 sale | 1,057 | $4k | 2.2% | No plan | SEC |
| Feb 14, 2023 | Feb 15, 2023 | ANNX | EVP & Chief Financial Officer | Form 4 sale | 1,908 | $12k | 6.1% | Plan not stated | SEC |
| Sep 13, 2021 | Sep 15, 2021 | ANNX | EVP & Chief Financial Officer | Form 4 sale | 3,500 | $70k | 63.6% | Unusual | SEC |
| May 27, 2021 | Jun 1, 2021 | ANNX | EVP & Chief Financial Officer | Form 4 sale | 3,500 | $78k | 63.6% | Unusual | SEC |
| Mar 23, 2021 | Mar 25, 2021 | ANNX | EVP & Chief Financial Officer | Form 4 sale | 5,000 | $142k | 71.4% | Unusual | SEC |
| May 1, 2019 | May 3, 2019 | CHINOOK THERAPEUTICS, INC. | Chief Financial Officer | Form 4 sale | 18,602 | $78k | 12.1% | Plan not stated | SEC |
| Apr 8, 2019 | Apr 10, 2019 | CHINOOK THERAPEUTICS, INC. | Chief Financial Officer | Form 4 sale | 18,601 | $76k | 12.1% | Plan not stated | SEC |
| Dec 12, 2018 | Dec 14, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Financial Officer | Form 4 sale | 1,035 | $3k | 0.8% | Plan not stated | SEC |
| Sep 13, 2018 | Sep 14, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Financial Officer | Form 4 sale | 5,623 | $37k | 4.0% | Plan not stated | SEC |
| Dec 1, 2017 | Dec 4, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,600 | $62k | 9.6% | Plan not stated | SEC |
| Nov 15, 2017 | Nov 17, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,600 | $59k | 9.6% | Plan not stated | SEC |
| Oct 2, 2017 | Oct 4, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,600 | $70k | 9.6% | Plan not stated | SEC |
| Sep 13, 2017 | Sep 14, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 3,557 | $39k | 5.4% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 6, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,600 | $77k | 13.4% | Plan not stated | SEC |
| Aug 7, 2017 | Aug 9, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,600 | $80k | 13.4% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 6, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 12,000 | $134k | 22.0% | Plan not stated | SEC |
| Jun 28, 2017 | Jun 30, 2017 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 12,000 | $134k | 22.0% | Plan not stated | SEC |
| Nov 10, 2016 | Nov 14, 2016 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 10,910 | $163k | 20.4% | Plan not stated | SEC |
| Sep 19, 2016 | Sep 21, 2016 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,360 | $95k | 13.0% | Plan not stated | SEC |
| Jan 6, 2016 | Jan 6, 2016 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 5,242 | $135k | 45.8% | Unusual | SEC |
| Dec 3, 2015 | Dec 7, 2015 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 5,242 | $156k | 72.4% | Unusual | SEC |
| Nov 18, 2015 | Nov 18, 2015 | CHINOOK THERAPEUTICS, INC. | Sr. Vice President of Finance | Form 4 sale | 6,712 | $191k | 77.0% | Unusual | SEC |
| Sep 14, 2012 | Sep 14, 2012 | DYNAVAX TECHNOLOGIES CORP | VP, Finance & PAO | Form 4 sale | 18,750 | $85k | 88.9% | Unusual | SEC |